Kawasaki Ninja ZX-10R Price starts at Rs. 19.78 Lakh which is Rs. 18.15 Lakh costlier than base model of Hero XPulse 210 priced at Rs. 1.63 Lakh. The claimed mileage of Hero XPuls ...
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price ...
Compare Honda CB300R vs Kawasaki Ninja ZX-10R - Compare Honda CB300R with Kawasaki Ninja ZX-10R by price, specifications, features, mileage, engine performance, colours, images, etc at ZigWheels.
Over the years, the Siena International Photo Awards has built a remarkable archive through its “Photo of the Day” series, ...
Add Yahoo as a preferred source to see more of our stories on Google. Air India is set to introduce a new policy that could place cabin crew members on leave without pay if their body weight falls ...
Air India is reportedly launching the controversial new policy in May Satyabrata Tripathy/Hindustan Times via Getty Air India has reportedly launched a new policy where cabin crew's pay could be ...
Air India is set to introduce a new policy that could place cabin crew members on leave without pay if their body weight falls outside company guidelines, according to multiple reports. Trump issues ...
The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...
Repeating the same meals and keeping calorie intake steady produced more weight loss than eating a more varied diet among individuals living with overweight or obesity, a short-term trial showed.
AI is revolutionizing market operations, prompting competition authorities to recalibrate regulations around automated decisions. Businesses are now liable for AI implications, not just their ...
Following the March 20 patent cliff, the Indian government has intensified surveillance on GLP-1 weight loss drugs, targeting unauthorised sales at wellness clinics and online pharmacies. As the ...
With generic versions of semaglutide flooding the India market — after Novo Nordisk lost the patent for its blockbuster weight-loss drug on March 20 — the country’s apex drug regulator has intensified ...